Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 736384, 7 pages
http://dx.doi.org/10.1155/2012/736384
Clinical Study

Spondyloarthropathies in Autoimmune Diseases and Vice Versa

1Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 # 63-C-69, Bogotá, Colombia
2Rheumatology Unit, Riesgo de Fractura-CAYRE IPS, Bogotá, Colombia

Received 15 October 2011; Revised 22 November 2011; Accepted 30 November 2011

Academic Editor: Mario García-Carrasco

Copyright © 2012 Oscar M. Pérez-Fernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Reveille and F. C. Arnett, “Spondyloarthritis: update on pathogenesis and management,” American Journal of Medicine, vol. 118, no. 6, pp. 592–603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Olivieri, A. van Tubergen, C. Salvarani, and S. van der Linden, “Seronegative spondyloarthritides,” Best Practice and Research, vol. 16, no. 5, pp. 723–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Rudwaleit, D. van der Heijde, R. Landewé et al., “The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general,” Annals of the Rheumatic Diseases, vol. 70, no. 1, pp. 25–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Rudwaleit, D. van der Heijde, R. Landewé et al., “The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 777–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Zeidler and B. Amor, “The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress,” Annals of the Rheumatic Diseases, vol. 70, no. 1, pp. 1–3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-M. Anaya, Y. Shoenfeld, P. Correa, M García-Carrasco, and R. Cervera, “Autoinmunidad y enfermedad autoinmune: el mosaico de la autoinmunidad,” in Autoinmunidad y Enfermedad Autoinmune, CIB, Ed., pp. 183–201, Medellín, Colombia, 2005. View at Google Scholar
  7. N. R. Rose and C. Bona, “Defining criteria for autoimmune diseases (Witebsky's postulates revisited),” Immunology Today, vol. 14, no. 9, pp. 426–430, 1993. View at Google Scholar · View at Scopus
  8. D. McGonagle and M. F. McDermott, “A proposed classification of the immunological diseases,” PLoS Medicine, vol. 3, no. 8, pp. 1242–1248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and rheumatism, vol. 40, no. 9, article 1725, 1997. View at Google Scholar · View at Scopus
  10. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  11. C. Vitali, S. Bombardieri, R. Jonsson et al., “Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 554–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. van der Linden, H. A. Valkenburg, and A. Cats, “Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria,” Arthritis and Rheumatism, vol. 27, no. 4, pp. 361–368, 1984. View at Google Scholar · View at Scopus
  13. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, and H. Mielants, “Classification criteria for psoriatic arthritis: development of new criteria from a large international study,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2665–2673, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Satsangi, M. S. Silverberg, S. Vermeire, and J. F. Colombel, “The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications,” Gut, vol. 55, no. 6, pp. 749–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Dougados, S. van der Linden, R. Juhlin et al., “The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy,” Arthritis and Rheumatism, vol. 34, no. 10, pp. 1218–1227, 1991. View at Google Scholar · View at Scopus
  16. G. S. Cooper and B. C. Stroehla, “The epidemiology of autoimmune diseases,” Autoimmunity Reviews, vol. 2, no. 3, pp. 119–125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. D. Reveille, “Epidemiology of spondyloarthritis in North America,” American Journal of the Medical Sciences, vol. 341, no. 4, pp. 284–286, 2011. View at Publisher · View at Google Scholar
  18. E. Haglund, A. B. Bremander, I. F. Petersson et al., “Prevalence of spondyloarthritis and its subtypes in southern Sweden,” Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 943–948, 2011. View at Publisher · View at Google Scholar
  19. M. J. Cross, E. U. R. Smith, J. Zochling, and L. M. March, “Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: epidemiology,” Clinical and Experimental Rheumatology, vol. 27, no. 4, pp. S36–S42, 2009. View at Google Scholar · View at Scopus
  20. J. Zochling and E. U. R. Smith, “Seronegative spondyloarthritis,” Best Practice and Research, vol. 24, no. 6, pp. 747–756, 2010. View at Publisher · View at Google Scholar
  21. K. Sundquist, J. C. Martineus, X. Li, K. Hemminki, and J. Sundquist, “Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalizations in Sweden between 1973 and 2004,” Rheumatology, vol. 47, no. 8, pp. 1199–1202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Borman, F. Ayhan, and M. Okumuş, “Coexistence of rheumatoid arthritis and ankylosing spondylitis,” Clinical Rheumatology, vol. 30, no. 11, pp. 1517–1518, 2011. View at Publisher · View at Google Scholar
  23. B. Baksay, A. Dér, Z. Szekanecz, S. Szántó, and A. Kovács, “Coexistence of ankylosing spondylitis and rheumatoid arthritis in a female patient,” Clinical Rheumatology, vol. 30, no. 8, pp. 1119–1122, 2011. View at Publisher · View at Google Scholar
  24. E. Toussirot and P. C. Acquaviva, “Coexisting rheumatoid arthritis and ankylosing spondylitis. Discussion of 3 cases with review of the literature,” Clinical Rheumatology, vol. 14, no. 5, pp. 554–560, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. E. L. Alexander, W. B. Bias, and F. C. Arnett, “The coexistence of rheumatoid arthritis with Reiter's syndrome and/or ankylosing spondylitis: a model of dual HLA-associated disease susceptibility and expression,” Journal of Rheumatology, vol. 8, no. 3, pp. 398–404, 1981. View at Google Scholar · View at Scopus
  26. E. Toussirot and D. Wendling, “Crohn's disease associated with seropositive rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 15, no. 3, pp. 307–311, 1997. View at Google Scholar · View at Scopus
  27. D. A. Johnson, A. M. Diehl, F. D. Finkelman, and E. L. Cattau Jr., “Crohn's disease and systemic lupus erythematosus,” American Journal of Gastroenterology, vol. 80, no. 11, pp. 869–870, 1985. View at Google Scholar · View at Scopus
  28. R. Cohen, D. Robinson, C. Paramore, K. Fraeman, K. Renahan, and M. Bala, “Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002,” Inflammatory Bowel Diseases, vol. 14, no. 6, pp. 738–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. I. E. Koutroubakis, K. Karmiris, L. Bourikas, E. A. Kouroumalis, I. Drygiannakis, and D. Drygiannakis, “Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations,” Inflammatory Bowel Diseases, vol. 13, no. 4, pp. 504–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Mrabet, S. Rekik, H. Sahli et al., “Ankylosing spondylitis in female systemic lupus erythematosus: a rare combination,” Lupus, vol. 20, no. 7, pp. 777–778, 2011. View at Publisher · View at Google Scholar
  31. C. Pérez-García, J. Maymo, M. P. Lisbona Pérez, M. Almirall Bernabé, and J. Carbonell Abelló, “Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab,” Rheumatology, vol. 45, no. 1, pp. 114–116, 2006. View at Publisher · View at Google Scholar
  32. H. Bodur, F. Eser, S. Konca, and S. ArIkan, “Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis,” Rheumatology International, vol. 29, no. 4, pp. 451–454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Mounach, M. Ghazi, A. Nouijai et al., “Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab,” Clinical and Experimental Rheumatology, vol. 26, no. 6, pp. 1116–1118, 2008. View at Google Scholar · View at Scopus
  34. S. Kobak, A. Celebi Kobak, Y. Kabasakal, and E. Doganavsargil, “Sjögren's syndrome in patients with ankylosing spondylitis,” Clinical Rheumatology, vol. 26, no. 2, pp. 173–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Brandt, M. Rudwaleit, U. Eggens et al., “Increased frequency of Sjogren's syndrome in patients with spondyloarthropathy,” Journal of Rheumatology, vol. 25, no. 4, pp. 718–724, 1998. View at Google Scholar · View at Scopus
  36. M. P. J. Vanderpump and W. M. G. Tunbridge, “Epidemiology and prevention of clinical and subclinical hypothyroidism,” Thyroid, vol. 12, no. 10, pp. 839–847, 2002. View at Google Scholar · View at Scopus
  37. A. Antonelli, A. Delle Sedie, P. Fallahi et al., “High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis,” Journal of Rheumatology, vol. 33, no. 10, pp. 2026–2028, 2006. View at Google Scholar · View at Scopus
  38. N. Kale, M. Icen, J. Agaoglu, I. Yazici, and O. Tanik, “Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders,” Neurological Sciences, vol. 29, no. 6, pp. 471–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. J. D. Londoño, L. A. González, L. A. Ramirez et al., “Caracterización de las espondiloartropatías y determinación de factores de mal pronóstico en una población de pacientes colombianos,” Revista Colombiana de Reumatología, vol. 12, pp. 195–207, 2005. View at Google Scholar
  40. J. Marquez, L. Pinto, D. L. Candia et al., “Espondiloartritis en el Hospital Pablo Tobón Uribe. Descripción de una cohorte,” Revista Colombiana de Reumatología, vol. 17, pp. 80–85, 2010. View at Google Scholar
  41. B. Martínez, L. Caraballo, M. Hernández, R. Valle, M. Ávila, and A. I. Gamarra, “HLA-B27 subtypes in patients with ankylosing spondylitis (As) in Colombia,” Revista de Investigacion Clinica, vol. 51, no. 4, pp. 221–226, 1999. View at Google Scholar · View at Scopus